These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8142661)

  • 41. Serum interleukin-3 levels following autologous or allogeneic bone marrow transplantation: effects of T-cell depletion, blood stem cell infusion, and hematopoietic growth factor treatment.
    Mangan KF; Mullaney MT; Barrientos TD; Kernan NA
    Blood; 1993 Apr; 81(7):1915-22. PubMed ID: 8096407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of erythropoietin in the treatment of post-bone marrow transplantation anemia.
    Vannucchi AM; Bosi A; Grossi A; Guidi S; Saccardi R; Bacci P; Lombardini L; Rossi-Ferrini P
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():8-12. PubMed ID: 8014003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation.
    Schriber JR; Chao NJ; Long GD; Negrin RS; Tierney DK; Kusnierz-Glaz C; Lucas KS; Blume KG
    Blood; 1994 Sep; 84(5):1680-4. PubMed ID: 7520782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early detection of bone marrow engraftment by amplification of hypervariable DNA regions.
    Martinelli G; Trabetti E; Farabegoli P; Testoni N; Bandini G; Motta MR; Vittone A; Terragna C; Pignatti PF; Tura S
    Haematologica; 1997; 82(2):156-60. PubMed ID: 9175318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients.
    Gentile G; Capobianchi A; Volpi A; Palù G; Pica F; Calistri A; Biasolo MA; Martino P
    J Natl Cancer Inst; 2005 Jul; 97(13):1008-11. PubMed ID: 15998954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation.
    Schmitz N; Bacigalupo A; Hasenclever D; Nagler A; Gluckman E; Clark P; Bourquelot P; Greinix H; Frickhofen N; Ringdén O; Zander A; Apperley JF; Gorin C; Borkett K; Schwab G; Goebel M; Russell NH; Gratwohl A
    Bone Marrow Transplant; 1998 May; 21(10):995-1003. PubMed ID: 9632272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin.
    Paltiel O; Cournoyer D; Rybka W
    Transfusion; 1993 May; 33(5):418-21. PubMed ID: 8488547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts.
    Adkins D; Spitzer G; Johnston M; Velasquez W; Dunphy F; Petruska P
    Transfusion; 1997 Jul; 37(7):737-48. PubMed ID: 9225939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors.
    Hallstrand TS; Sprenger JD; Agosti JM; Longton GM; Witherspoon RP; Henderson WR
    Blood; 2004 Nov; 104(10):3086-90. PubMed ID: 15280196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation.
    Ji SQ; Chen HR; Xun CQ; Wang HX; Pan SP; Xiao MH
    Clin Transplant; 2001 Oct; 15(5):317-23. PubMed ID: 11678957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study.
    Nagel RL; Vichinsky E; Shah M; Johnson R; Spadacino E; Fabry ME; Mangahas L; Abel R; Stamatoyannopoulos G
    Blood; 1993 Jan; 81(1):9-14. PubMed ID: 8417806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease.
    Waller EK; Ship AM; Mittelstaedt S; Murray TW; Carter R; Kakhniashvili I; Lonial S; Holden JT; Boyer MW
    Blood; 1999 Nov; 94(9):3222-33. PubMed ID: 10556211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors.
    Berger C; Bertz H; Schmoor C; Behringer D; Potthoff K; Mertelsmann R; Finke J
    Bone Marrow Transplant; 1999 May; 23(10):983-90. PubMed ID: 10373062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perioperative recombinant human erythropoietin.
    Levine EA; Gould SA; Rosen AL; Sehgal LR; Egrie JC; Sehgal HL; Levine HD; Moss GS
    Surgery; 1989 Aug; 106(2):432-7; discussion 437-8. PubMed ID: 2763040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
    Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.
    Meier JA; Haque M; Fawaz M; Abdeen H; Coffey D; Towlerton A; Abdeen A; Toor A; Warren E; Reed J; Kanakry CG; Keating A; Luznik L; Toor AA
    Biol Blood Marrow Transplant; 2019 May; 25(5):868-882. PubMed ID: 30677510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.